Discover more insights into Hbsag Clearance Hbsagクリアランス

Keywords frequently search together with Hbsag Clearance Hbsagクリアランス

Narrow sentence examples with built-in keyword filters

Hbsag Clearance sentence examples within Achieve Hbsag Clearance



A210 DECLINE IN HEPATITIS B QUANTITATIVE SURFACE ANTIGEN LEVELS IN CHRONIC HEPATITIS B PATIENTS ON TREATMENT WITH NUCLEOS(T)IDE ANALOGUES


Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAg

Hbsag Clearance sentence examples within Serum Hbsag Clearance



Novel monkey mAbs induced by a therapeutic vaccine targeting the hepatitis B surface antigen effectively suppress hepatitis B virus in mice


Clinical follow-up of children with immune-tolerant chronic hepatitis B receiving antiviral therapy

Hbsag Clearance sentence examples within hbsag clearance rate



Current status and perspectives of the clinical and basic research on concomitant chronic hepatitis B virus infection and nonalcoholic fatty liver disease


Electronic Health Informatics Data To Describe Clearance Dynamics of Hepatitis B Surface Antigen (HBsAg) and e Antigen (HBeAg) in Chronic Hepatitis B Virus Infection


Learn more from Hbsag Clearance Hbsagクリアランス



Editorial: natural history of hepatitis delta virus‐induced liver disease ‐ less severe today but still needs attention



Kinetics of quantitative hepatitis B surface antigen in patients with rheumatic disease and chronic hepatitis B receiving biologic agents.



A simple-to-use tool for predicting response to peginterferon in HBV DNA suppressed chronic hepatitis B patients in China.



Functional cure for chronic hepatitis B: accessibility, durability, and prognosis



[Quantitative hepatitis B core antibody levels can be used as a predictive index of HBsAg clearance].



Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy.



Anti-hepatitis B activities of Myanmar medicinal plants: a narrative review of current evidence.



Analysis of the Efficacy and Safety of PEGylated Interferon-α2b Treatment in Inactive Hepatitis B Surface Antigen Carriers



Discontinuation of nucleot(s)ide analogue therapy in HBeAg-negative chronic hepatitis B: a meta-analysis



Resolved Hepatitis B: Achieved or Imaginary Wellbeing?



[Early reduction of serum RANTES can predict HBsAg clearance in patients with chronic hepatitis B treated with nucleos(t)ide analogues combined with peginterferon alpha].



Risks and Benefits of Discontinuation of Nucleos(t)ide Analogue Treatment: A Treatment Concept for Patients With HBeAg‐Negative Chronic Hepatitis B



Mortality of inactive hepatitis B virus carriers in Japan is similar to that of the general population.



Hepatocyte-derived L-carnitine restricts hepatitis B surface antigen loss through an immunosuppressive effect on germinal center-related immune cells.



Incidence and Predictors of Hepatitis B Surface Antigen Clearance in HIV Patients: A Retrospective Multisite Study



Highly Accurate, Specific And Sensitive Quantitation By Droplet Digital PCR Reveals The Stability of Intrahepatic Hepatitis B Virus cccDNA



Influencing factors for serum HBsAg clearance in people with chronic hepatitis B virus infection and its clinical significance



[Association of baseline alanine aminotransferase levels with therapeutic effects of entecavir and interferon-α in patients with chronic hepatitis B].



Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection



Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B.


More Hbsag Clearance Hbsagクリアランス sentence examples
10.3760/cma.j.issn.1007-3418.2019.11.004

[Effect of chronic hepatitis B virus DNA negative transformation and HBsAg clearance on the occurrence of hepatocellular carcinoma].



Early Serum HBsAg Drop Is a Strong Predictor of HBeAg Seroconversion and HBsAg Loss to Pegylated Interferon Alfa-2a in Chronic Hepatitis B Patients with Prior Nucleos(t)ide Analogue Exposure



A ‘sandwich’ strategy promises functional cure of chronic hepatitis B



Efficacy and safety of interferon alpha therapy in children with chronic hepatitis B


More Hbsag Clearance Hbsagクリアランス sentence examples
10.3760/cma.j.issn.1007-3418.2019.08.004

[A randomized controlled study on factors influencing the curative effect of sequential combined interferon and lamivudine therapy in children with immune-tolerant phase chronic hepatitis B].


More Hbsag Clearance Hbsagクリアランス sentence examples
10.3760/cma.j.issn.1007-3418.2019.08.001

[Pursuit of anti-hepatitis B virus therapy].



Efficacy and safety of interferon alpha-2b versus pegylated interferon alpha-2a monotherapy in children with chronic hepatitis B: a real-life cohort study from Shanghai, China



On the way towards the eradication of chronic hepatitis B



Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon‐based therapy in patients with hepatitis B e antigen‐negative chronic hepatitis B



Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection



The effect of thymopentin add-on in hepatitis B e antigen positive chronic hepatitis B after virus suppression by peginterferon plus entecavir therapy.



Quantitative of serum hepatitis B core antibody is a potential predictor of recurrence after interferon-induced hepatitis B surface antigen clearance.



Predictors of sustained functional cure in hepatitis B envelope antigen‐negative patients achieving hepatitis B surface antigen seroclearance with interferon‐alpha–based therapy


More Hbsag Clearance Hbsagクリアランス sentence examples
10.3877/CMA.J.ISSN.1674-1358.2019.04.003

Effect of antiviral therapy combined with interferon on negative conversion rate of surface antigen among patients of chronic hepatitis B treated with nucleos(t)ide analogues



Long‐term efficacy and safety of peginterferon in the treatment of children with HBeAg‐positive chronic hepatitis B


Learn more from Hbsag Clearance Hbsagクリアランス

Hbsag Clearance Hbsagクリアランスの概要


Hbsag Clearance Hbsagクリアランス
Encyclopedia 百科事典